Results 101 to 110 of about 19,928 (218)

CNC–PNIPAM Drug Delivery System Improves Endometrial Receptivity via Natural Killer Cell Immune Tolerance in Endometriosis

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 5, May 2026.
An injectable CNC–PNIPAM hydrogel is developed for intrauterine co‐delivery of levonorgestrel and botropase. This platform reprograms uterine natural killer cells toward an immune–tolerant phenotype and enhances endometrial receptivity marker expression. The results demonstrate a promising strategy to counteract endometriosis–associated infertility and
Zhou Liang   +9 more
wiley   +1 more source

Women's knowledge about Intrauterine Device and user satisfaction in Brazil: a systematic review. [PDF]

open access: yesRev Esc Enferm USP
Sousa COGL   +4 more
europepmc   +1 more source

Contributing Factors, Gaps in Research, and the Complex History of Intrauterine Device Insertion Pain in the United States [PDF]

open access: yes
Intrauterine devices (IUDs) are a form of contraception that boast high efficacy, affordability, and ease of use. However, these devices are considered underutilized in the United States, where contraceptive education and accessibility are a consistent ...
Stephenson, Kathleen Megan
core   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1385-1396, May 2026.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman   +6 more
wiley   +1 more source

Efficacy of Fertility‐Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
Molecular profiles and outcomes of CR rate in 74 cases. ABSTRACT Objective To investigate the impact of various molecular characteristics on the outcomes of fertility‐preserving therapy in patients with endometrial cancer (EC) and atypical endometrial hyperplasia (AEH).
Xue‐Qian Qian   +4 more
wiley   +1 more source

Candida glabrata Isolated From Tubo‐Ovarian Abscess Cultures in Two Immunocompetent Patients

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
Persistent 7.3 × 5.8 cm TOA unresponsive to 4 weeks of antibiotic treatment and percutaneous drainage, growing Candida glabrata on cultures. ABSTRACT In this clinical case report, we present two immunocompetent patients with tubo‐ovarian abscesses (TOAs) that were positive for Candida glabrata.
Marlee Hirsch   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy